1 / 15

Short hairpin RNAs

Short hairpin RNAs. Dave Lyons May 2009. Short hairpin RNAs. Discovery of interfering RNAs shRNAs in biology shRNAs in medicine. Short hairpin RNAs. Discovery of interfering RNAs shRNAs in biology shRNAs in medicine. Discovery of RNAi. 1990. 2000. 2010. “Invention” of shRNA. 2000.

adenton
Download Presentation

Short hairpin RNAs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Short hairpin RNAs Dave Lyons May 2009

  2. Short hairpin RNAs • Discovery of interfering RNAs • shRNAs in biology • shRNAs in medicine

  3. Short hairpin RNAs • Discovery of interfering RNAs • shRNAs in biology • shRNAs in medicine

  4. Discovery of RNAi . . . 1990 2000 2010

  5. “Invention” of shRNA 2000 2010 Paddison et al. 2002

  6. “Invention” of shRNA Paddison et al. 2002; Rao et al. 2009

  7. Short hairpin RNAs • Discovery of interfering RNAs • shRNAs in biology • shRNAs in medicine

  8. shRNA in biological research • Large-scale screens • In vivo studies • Validation

  9. shRNAs for large-scale screens Dykxhoorn and Lieberman 2005

  10. 2.) Transplantation of infected SCs 3.) Infect mouse with vector shRNAs for in vivo studies 1.) Mouse KO / KI / BAC Dykxhoorn and Lieberman 2005

  11. Pol III promoter Pol II promoter shRNAs for in vivo studies 4.) Tail vein injection Dykxhoorn and Lieberman 2005; Giering et al. 2008

  12. shRNA - validation 4.) Tail vein injection Off-target effects? Pol III promoter Pol III promoter Pol II promoter Pol II promoter Dykxhoorn and Lieberman 2005; Giering et al. 2008

  13. shRNA - validation 1.) need a phenotypic assay to accurately confirm on-target effect. 2.) need to control for specific and non-specific off-target effects. - expression profiling of transfected controls - general immune response? - bottleneck effects (e.g. nuclear export)

  14. Short hairpin RNAs • Discovery of interfering RNAs • shRNAs in biology • shRNAs in medicine

  15. shRNA in medicine • shRNA is difficult to deliver without viruses but in vivo experiments in mouse suggest better overall for specificity than siRNA. • Successful viral targeting is central to future of shRNA therapeutics. • Clinical trials with siRNA outnumber shRNA currently.

More Related